Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 45.06 USD -0.92% Market Closed
Market Cap: 2.2B USD
Have any thoughts about
Amphastar Pharmaceuticals Inc?
Write Note

Amphastar Pharmaceuticals Inc
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amphastar Pharmaceuticals Inc
Long-Term Debt Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Long-Term Debt
$586.9m
CAGR 3-Years
168%
CAGR 5-Years
71%
CAGR 10-Years
30%
Johnson & Johnson
NYSE:JNJ
Long-Term Debt
$31.3B
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
9%
Bristol-Myers Squibb Co
NYSE:BMY
Long-Term Debt
$48.7B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
21%
Pfizer Inc
NYSE:PFE
Long-Term Debt
$57.5B
CAGR 3-Years
17%
CAGR 5-Years
10%
CAGR 10-Years
6%
Merck & Co Inc
NYSE:MRK
Long-Term Debt
$35B
CAGR 3-Years
15%
CAGR 5-Years
9%
CAGR 10-Years
7%
Eli Lilly and Co
NYSE:LLY
Long-Term Debt
$29B
CAGR 3-Years
23%
CAGR 5-Years
16%
CAGR 10-Years
19%

See Also

What is Amphastar Pharmaceuticals Inc's Long-Term Debt?
Long-Term Debt
586.9m USD

Based on the financial report for Jun 30, 2024, Amphastar Pharmaceuticals Inc's Long-Term Debt amounts to 586.9m USD.

What is Amphastar Pharmaceuticals Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
30%

Over the last year, the Long-Term Debt growth was 20%. The average annual Long-Term Debt growth rates for Amphastar Pharmaceuticals Inc have been 168% over the past three years , 71% over the past five years , and 30% over the past ten years .

Back to Top